Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood coagulation.

Lucy A Norris1

  • 1Coagulation Research Laboratory, Department of Obstetrics and Gynaecology, Trinity College Centre for Health Sciences, St James's Hospital, 8, Dublin, Ireland. lnorris@tcd.ie

Best Practice & Research. Clinical Obstetrics & Gynaecology
|June 6, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of anticancer treatment-induced arterial and venous thrombosis.

Journal of thrombosis and haemostasis : JTH·2025
Same author

Circulating tumour cells are a prognostic indicator in advanced high-grade serous ovarian cancer and are associated with platelets and immune cells following dissemination.

British journal of cancer·2025
Same author

Plasminogen activator inhibitor 1 is associated with high-grade serous ovarian cancer metastasis and is reduced in patients who have received neoadjuvant chemotherapy.

Frontiers in cell and developmental biology·2023
Same author

"Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis": Comment.

Journal of thrombosis and haemostasis : JTH·2023
Same author

Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?

Molecular cancer·2021
Same author

Procoagulant activity in high grade serous ovarian cancer patients following neoadjuvant chemotherapy-The role of the activated protein C pathway.

Thrombosis research·2021

Blood coagulation involves two pathways, leading to thrombin formation for clot creation. This process is tightly regulated by inhibitors and the fibrinolytic system to prevent thrombosis.

Area of Science:

  • Biochemistry
  • Physiology
  • Hematology

Background:

  • Blood coagulation is a complex process essential for hemostasis.
  • It can be initiated via extrinsic or intrinsic pathways.
  • Dysregulation can lead to thrombotic disorders.

Purpose of the Study:

  • To summarize the key mechanisms of blood coagulation.
  • To highlight the regulatory pathways involved.
  • To underscore factors influencing coagulation and thrombosis.

Main Methods:

  • Review of established literature on coagulation pathways.
  • Description of enzymatic cascades and regulatory proteins.
  • Discussion of genetic and environmental influences.

Related Experiment Videos

Main Results:

  • Coagulation involves sequential activation of serine proteases, forming thrombin and fibrin clots.
  • Key regulatory mechanisms include tissue factor pathway inhibitor, antithrombin, and Protein C/S system.
  • The fibrinolytic system counteracts excess fibrin deposition.

Conclusions:

  • Blood coagulation is a finely tuned process with multiple checks and balances.
  • Imbalances in coagulation regulation can increase thrombosis risk.
  • Understanding these pathways is crucial for managing bleeding and clotting disorders.